Novel allosteric effects of amiodarone at the muscarinic M5 receptor

Journal of Pharmacology and Experimental Therapeutics

Volumn 334, Issue 1, 2010, Pages 214-222

  Stahl, Edward ^a   Ellis, John ^a  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; AMIODARONE; GALLAMINE; METHYLSCOPOLAMINE; MUSCARINIC M1 RECEPTOR; MUSCARINIC M5 RECEPTOR; OBIDOXIME;

ALLOSTERISM; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; DISSOCIATION; DRUG ANTAGONISM; DRUG BINDING; DRUG EFFICACY; NONHUMAN; PRIORITY JOURNAL;

ALLOSTERIC REGULATION; ALLOSTERIC SITE; AMIODARONE; ANIMALS; ANTI-ARRHYTHMIA AGENTS; BINDING, COMPETITIVE; CELL MEMBRANE; CHO CELLS; CRICETINAE; CRICETULUS; LIGANDS; RADIOLIGAND ASSAY; RECEPTOR, MUSCARINIC M1; RECEPTOR, MUSCARINIC M5;

EID: 77953791638     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.109.165316     Document Type: Article

References (40)

1. Anagnostaras SG, Murphy GG, Hamilton SE, Mitchell SL, Rahnama NP, Nathanson NM, and Silva AJ (2003) Selective cognitive dysfunction in acetylcholine M1 muscarinic receptor mutant mice. Nat Neurosci 6:51-58.
2. Araya R, Noguchi T, Yuhki M, Kitamura N, Higuchi M, Saido TC, Seki K, Itohara S, Kawano M, Tanemura K, Takashima A, Yamada K, Kondoh Y, Kanno I, Wess J, and Yamada M (2006) Loss of M5 muscarinic acetylcholine receptors leads to cerebrovascular and neuronal abnormalities and cognitive deficits in mice. Neurobiol Dis 24:334-344.
3. Birdsall NJ, Farries T, Gharagozloo P, Kobayashi S, Kuonen D, Lazareno S, Popham A, and Sugimoto M (1997) Selective allosteric enhancement of the binding and actions of acetylcholine at muscarinic receptor subtypes. Life Sci 60:1047-1052.
4. Bridges TM, Marlo JE, Niswender CM, Jones CK, Jadhav SB, Gentry PR, Plumley HC, Weaver CD, Conn PJ, and Lindsley CW (2009) Discovery of the first highly M5-preferring muscarinic acetylcholine receptor ligand, an M5 positive allosteric modulator derived from a series of 5-trifluoromethoxy N-benzyl isatins. J Med Chem 52:3445-3448.
5. Bymaster FP, Calligaro DO, and Falcone JF (1999) Arachidonic acid release in cell lines transfected with muscarinic receptors: a simple functional assay to determine response of agonists. Cell Signal 11:405-413.
6. Christopoulos A and Kenakin T (2002) G protein-coupled receptor allosterism and complexing. Pharmacol Rev 54:323-374.
7. Cohen-Armon M, Schreiber G, and Sokolovsky M (1984) Interaction of the antiarrhythmic drug amiodarone with the muscarinic receptor in rat heart and brain. J Cardiovasc Pharmacol 6:1148-1155. (Pubitemid 15193272)
8. Colvin RA, Oibo JA, Allen RA, Tyler L, and Leek D (1989) Interaction of amiodarone and desethylamiodarone with the cardiac muscarinic receptor in vitro. J Mol Cell Cardiol 21:453-460.
9. Conklin BR, Brann MR, Buckley NJ, Ma AL, Bonner TI, and Axelrod J (1988) Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells. Proc Natl Acad Sci USA 85:8698-8702.
10. Conn PJ, Jones CK, and Lindsley CW (2009) Subtype-selective allosteric modulators of muscarinic receptors for the treatment of CNS disorders. Trends Pharmacol Sci 30:148-155.
11. Ehlert FJ (1988) Estimation of the affinities of allosteric ligands using radioligand binding and pharmacological null methods. Mol Pharmacol 33:187-194.
12. Ehlert FJ (2005) Analysis of allosterism in functional assays. J Pharmacol Exp Ther 315:740-754.
13. Ellis J (1997) Allosteric binding sites on muscarinic receptors. Drug Dev Res 40:193-204.
14. Ellis J (2002) Muscarinic receptors, in Understanding G Protein-Coupled Receptors and their Role in the CNS (Davies and Pangalos eds), Oxford University Press, London, UK.
15. Ellis J and Seidenberg M (1992) Two allosteric modulators interact at a common site on cardiac muscarinic receptors. Mol Pharmacol 42:638-641. (Pubitemid 23027627)
16. Ellis J and Seidenberg M (1999) Competitive and allosteric interactions of 6-chloro- 5,10-dihydro-5-[(1-methyl-4-piperidinyl)acetyl]-11H-di benzo[b,e][1,4]diazepine- 11-one hydrochloride (UH-AH 37) at muscarinic receptors, via distinct epitopes. Biochem Pharmacol 57:181-186.
17. Ellis J and Seidenberg M (2000) Interactions of alcuronium, TMB-8, and other allosteric ligands with muscarinic acetylcholine receptors: studies with chimeric receptors. Mol Pharmacol 58:1451-1460.
18. Ellis J, Huyler J, and Brann MR (1991) Allosteric regulation of cloned m1-m5 muscarinic receptor subtypes. Biochem Pharmacol 42:1927-1932.
19. Ellis J, Seidenberg M, and Brann MR (1993) Use of chimeric muscarinic receptors to investigate epitopes involved in allosteric interactions. Mol Pharmacol 44:583-588. (Pubitemid 23280270)
20. Felder CC, Dieter P, Kinsella J, Tamura K, Kanterman RY, and Axelrod J (1990) A transfected m5 muscarinic acetylcholine receptor stimulates phospholipase A2 by inducing both calcium influx and activation of protein kinase C. J Pharmacol Exp Ther 255:1140-1147.
21. Hall DA (2000) Modeling the functional effects of allosteric modulators at pharmacological receptors: an extension of the two-state model of receptor activation. Mol Pharmacol 58:1412-1423.
22. Huang XP, Prilla S, Mohr K, and Ellis J (2005) Critical amino acid residues of the common allosteric site on the M2 muscarinic acetylcholine receptor: more similarities than differences between the structurally divergent agents gallamine and bis(ammonio)alkane-type hexamethylene-bis-[dimethyl-(3- phthalimidopropyl)ammonium] dibromide. Mol Pharmacol 68:769-778.
23. Jones SVP, Levey AI, Weiner DM, Ellis J, Novotny E, Yu S-H, Dorje F, Wess J and Brann MR (1992) Muscarinic acetylcholine receptors, in Molecular Biology of Receptors Which Couple to G-Proteins (Brann MR ed), Birkhauser, Boston, MA.
24. Kodama I, Kamiya K, and Toyama J (1997) Cellular electropharmacology of amiodarone. Cardiovasc Res 35:13-29.
25. Kostenis E and Mohr K (1996) Two-point kinetic experiments to quantify allosteric effects on radioligand dissociation. Trends Pharmacol Sci 17:280-283.
26. Langmead CJ, Watson J, and Reavill C (2008) Muscarinic acetylcholine receptors as CNS drug targets. Pharmacol Ther 117:232-243.
27. Lanzafame AA, Christopoulos A, and Mitchelson F (2003) Cellular signaling mechanisms for muscarinic acetylcholine receptors. Receptors Channels 9:241-260.
28. Lazareno S, Gharagozloo P, Kuonen D, Popham A, and Birdsall NJ (1998) Subtypeselective positive cooperative interactions between brucine analogues and acetylcholine at muscarinic receptors: radioligand binding studies. Mol Pharmacol 53: 573-589. (Pubitemid 28162882)
29. Lazareno S, Popham A, and Birdsall NJ (2000) Allosteric interactions of staurosporine and other indolocarbazoles with N-[methyl-(3)H]scopolamine and acetylcholine at muscarinic receptor subtypes: identification of a second allosteric site. Mol Pharmacol 58:194-207. (Pubitemid 30452543)
30. Lazareno S, Popham A, and Birdsall NJ (2002) Analogs of WIN 62,577 define a second allosteric site on muscarinic receptors. Mol Pharmacol 62:1492-1505.
31. Marlo JE, Niswender CM, Days EL, Bridges TM, Xiang Y, Rodriguez AL, Shirey JK, Brady AE, Nalywajko T, Luo Q, Austin CA, Williams MB, Kim K, Williams R, Orton D, Brown HA, Lindsley CW, Weaver CD, and Conn PJ (2009) Discovery and characterization of novel allosteric potentiators of M1 muscarinic receptors reveals multiple modes of activity. Mol Pharmacol 75:577-588.
32. Schnabel P, Mies F, Maack C, Rosenkranz S, Zolk O, and Böhm M (1999) Beneficial effects of amiodarone in heart failure: interaction with beta-adrenoceptors rather than G proteins. Eur J Pharmacol 369:391-394.
33. Shirey JK, Xiang Z, Orton D, Brady AE, Johnson KA, Williams R, Ayala JE, Rodriguez AL, Wess J, Weaver D, Niswender CM, and Conn PJ (2008) An allosteric potentiator of M4 mAChR modulates hippocampal synaptic transmission. Nat Chem Biol 4:42-50.
34. Tränkle C and Mohr K (1997) Divergent modes of action among cationic allosteric modulators of muscarinic M2 receptors. Mol Pharmacol 51:674-682. (Pubitemid 27172996)
35. Tränkle C, Dittmann A, Schulz U, Weyand O, Buller S, Jöhren K, Heller E, Birdsall NJ, Holzgrabe U, Ellis J, Höltje HD, and Mohr K (2005) Atypical muscarinic allosteric modulation: cooperativity between modulators and their atypical binding topology in muscarinic M2 and M2/M5 chimeric receptors. Mol Pharmacol 68:1597-1610.
36. Tränkle C, Kostenis E, Burgmer U, and Mohr K (1996) Search for lead structures to develop new allosteric modulators of muscarinic receptors. J Pharmacol Exp Ther 279:926-933. (Pubitemid 27166869)
37. Voigtländer U, Jöhren K, Mohr M, Raasch A, Tränkle C, Buller S, Ellis J, Höltje HD, and Mohr K (2003) Allosteric site on muscarinic acetylcholine receptors: identification of two amino acids in the muscarinic M2 receptor that account entirely for the M2/M5 subtype selectivities of some structurally diverse allosteric ligands in N-methylscopolamine-occupied receptors. Mol Pharmacol 64: 21-31.
38. Wess J, Eglen RM, and Gautam D (2007) Muscarinic acetylcholine receptors: mutant mice provide new insights for drug development. Nat Rev Drug Discov 6:721-733.
39. Yamada M, Lamping KG, Duttaroy A, Zhang W, Cui Y, Bymaster FP, McKinzie DL, Felder CC, Deng CX, Faraci FM, and Wess J (2001) Cholinergic dilation of cerebral blood vessels is abolished in M(5) muscarinic acetylcholine receptor knockout mice. Proc Natl Acad Sci USA 98:14096-14101.
40. Yin Y, Vassy R, Nicolas P, Perret GY, and Laurent S (1994) Antagonism between T3 and amiodarone on the contractility and the density of beta-adrenoceptors of chicken cardiac myocytes. Eur J Pharmacol 261:97-104.